| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |